Financial News
Latest News about ABBV
Recent news which mentions ABBV
From InvestorPlace
From Benzinga
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
June 19, 2023
From Motley Fool
Unlock the Potential of These 7 Cash-Flow Machines
June 18, 2023
From InvestorPlace
From Motley Fool
AbbVie vs Coherus: Dispute Emerges over Upcoming Launch of Low-Cost Biosimilar, Yusimry
June 15, 2023
From Benzinga
From Benzinga
From Benzinga
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices
June 12, 2023
From Benzinga
From Motley Fool
7 Top Blue-Chip Stocks to Buy in June 2023
June 11, 2023
From InvestorPlace
Better Long-Term Buy: AbbVie or Novo Nordisk?
June 10, 2023
From Motley Fool
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
From Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
June 08, 2023
From Benzinga
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion'
June 06, 2023
From Benzinga
From Motley Fool
From MarketWatch
7 Best Dividend Stocks to Buy Now in June 2023
June 01, 2023
From Motley Fool
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
June 01, 2023
From Benzinga
Why Is AbbVie Stock Trading Down Today?
June 01, 2023
From Benzinga
Why AbbVie and Amgen Are Moving Lower Today
June 01, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
